Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

41.77 +0.73 (+1.79%)
Streaming Delayed Price Updated: 3:16 PM EDT, Jun 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
58 59 Next >
Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy Shows Overall Survival and Progression-Free Survival Benefit for Cisplatin-Eligible Patients with Unresectable or Metastatic Urothelial Carcinoma in the Phase 3 CheckMate -901 Trial
From Bristol Myers Squibb
Via Business Wire
Arbutus Appoints Two New Executives
From Arbutus Biopharma Corporation
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 10, 2023
Via Benzinga
Looking Into Bristol-Myers Squibb's Recent Short Interest
Via Benzinga
Why Is Allarity Therapeutics (ALLR) Stock Up 30% Today?
Allarity Therapeutics became the toast of Wall Street Wednesday with positive early clinical data, though ALLR stock remains risky. 
Via InvestorPlace
Allarity Says Initial Data Show Improved Clinical Benefit In Breast Cancer Patients Selected Via Companion Diagnostic
Allarity Therapeutics Inc (NASDAQ: ALLR) announced initial results from its European Phase 2 clinical trial evaluating the efficacy of Ixempra in metastatic breast cancer (mBC) patients selected with... 
Via Benzinga
Evotec Secures US Government Contract For Orthopoxvirus Antibody
The U.S. 
Via Benzinga
3 Spectacular Dividend Stocks to Buy in July
Heat up your portfolio this month with these dividend stocks. 
Via The Motley Fool
Why Aurinia Pharmaceuticals Stock Is Marching Higher Friday
The biotech's board is exploring strategic alternatives to boost shareholder value. 
Via The Motley Fool
Check Out What Whales Are Doing With BMY
Via Benzinga
Bristol-Myers Squibb Unusual Options Activity
Via Benzinga
Analyst Expectations for Bristol-Myers Squibb's Future
Via Benzinga
5 High-Yielding Dividend Stocks That Are Bargain Buys
This is a good time for investors to load up on healthcare companies. 
Via The Motley Fool
Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) with Chemotherapy as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer at High Risk of Recurrence in Patients with Tumor Cell PD-L1 Expression ≥1%
From Bristol Myers Squibb
Via Business Wire
Survival Rates Improve with SELLAS's New Treatment for Severe Lung Cancer, Phase 1 Study Shows
SELLAS Life Sciences Group Inc (NASDAQ: SLS) released topline data from a Phase 1 trial of its lead clinical candidate, galinpepimut-S (GPS), combined with Bristol Myers Squibb Co (NYSE: BMY) nivolumab... 
Via Benzinga
Fresh Blood: 3 Stocks Ready to Rally Under New CEOs
Here are three companies with new CEOs that could rally in the year ahead as new management shakes things up. 
Via InvestorPlace
2 Stocks to Buy With $100 and Hold Forever
Both companies are leaders in industries that have excellent growth prospects. 
Via The Motley Fool
3 Bargain Stocks to Buy on the Dip
These stocks should be poised to rebound. 
Via The Motley Fool
Bristol Myers Squibb Receives European Commission Approval of CAMZYOS® (mavacamten), for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)
From Bristol Myers Squibb
Via Business Wire
2 Low-Priced Stocks That Could Make You Richer
These two low-priced healthcare stocks could skyrocket within the next 12 months. 
Via The Motley Fool
3 Healthcare Stocks That Are Too Cheap to Ignore
Each of these companies is trading at a valuation well below those of its industry peers. 
Via The Motley Fool
Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows
Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows 
Via News Direct
I'm Buying These 3 Resilient Stocks During a Bear Market
Be ready for the next bear market with stocks that bounce back fast. 
Via The Motley Fool
Will Johnson & Johnson Be a Trillion-Dollar Stock by 2038?
The healthcare company is already almost halfway there. 
Via The Motley Fool
7 Healthcare Stocks to Make You the Millionaire Next Door
For investors who want to greatly increase their wealth in the long term, these are the best healthcare stocks to buy. 
Via InvestorPlace
What's Going On With TRACON Pharmaceuticals Shares Today
TRACON Pharmaceuticals (NASDAQ: TCON) shares are trading lower Thursday morning after the company released the results of a six-month independent data monitoring committee (IDMC) review for the... 
Via Benzinga
3 AI Stocks That Could Skyrocket Your Wealth
AI is poised to greatly increase the top and bottom lines of many companies, making many AI stocks very attractive at this point. 
Via InvestorPlace
Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel) Delivers Deep and Durable Responses in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma in TRANSCEND Clinical Trials Presented at ICML 2023
From Bristol Myers Squibb
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
U.S. Food and Drug Administration Approves Addition of Positive Data from Phase 3 VALOR-HCM Study to CAMZYOS® (mavacamten) Label
From Bristol Myers Squibb
Via Business Wire
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
58 59 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.